Rejoni

RejoniRejoni
Rejoni

Rejoni

Elevating uterine health through innovative biomaterial therapies.

2018Active19
Rate

About

Rejoni, Inc. is a privately held, clinical-stage company focused on developing innovative biomaterial therapies to improve uterine health. Their lead product candidate is Juveena Hy.

Technology stack

detected 2026-07-01
CDN
Cloudflare
Emailunknown
Stack
Webflow
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Rejoni do?

Rejoni, Inc. is a privately held, clinical-stage company focused on developing innovative biomaterial therapies to improve uterine health. Their lead product candidate is Juveena Hy.

How much funding has Rejoni raised?

Rejoni has raised a total of $25M in funding. The most recent round on record is Funding Round.

Where is Rejoni headquartered?

Rejoni is headquartered in Bedford, Massachusetts, USA.

When was Rejoni founded?

Rejoni was founded in 2018.

What industry does Rejoni operate in?

Rejoni operates in Biotechnology, Healthcare, Medical Devices, Biotech, MedTech, HealthTech.

How many employees does Rejoni have?

Rejoni has approximately 19 people on record.

What is Rejoni's revenue?

StartupHub estimates Rejoni's annual revenue at $2.3M (range $1.3M to $7.3M, 71% confidence), based on comparable companies in the sector.

What is Rejoni's valuation?

StartupHub estimates Rejoni's effective valuation at $95.5M (range $62.5M to $150.0M, 25% confidence), based on comparable companies in the sector.